Clicky

Pluri Inc.(PLUR) News

Date Title
Jun 18 Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
May 12 Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)
May 2 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
Apr 8 Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
Mar 28 Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
Mar 27 Pluri Inc. Announces 1-for-8 Reverse Share Split
Mar 21 Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report
Mar 19 Engage with Pluri's Talent: Exciting Conference Appearances Ahead
Mar 14 Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
Mar 11 Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
Mar 6 Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board
Jan 23 Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis
Dec 21 Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction
Apr 27 Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based Products